Skip to content
PPD
Main Menu
  • Insights Hub
  • Careers
  • Contact Us
  • Investors
  • Newsroom
  • Japan
  • English
    • Français Canadien
  • Search
Search
  • Who We Are
    • Our Mission
      • Accolades
      • Our History
    • Our 4i Values
    • Our Work
      • Our Solutions
      • How We Help
      • Therapeutic Areas
    • Corporate Responsibility
      • Environmental Stewardship
      • Health and Wellness
      • Philanthropy
      • PPD Heroes
    • Locations
    • Company Resources
      • Vendor Resources
      • Legal Notices
      • Privacy Policy
      • Events
      • Newsroom
      • Ethics
      • Investors
  • How We Help
    • Clinical Trial Certainty/Reliability
    • Data Capabilities
    • Patient First Solutions
      • Choosing DCTs
      • DCT Capabilities and Solutions
      • DCT Therapeutic Expertise
      • Why DCT
      • Resources
    • Ensuring Patient Diversity in Clinical Trials
    • Expertise in Asia-Pacific
      • PPD in China
      • PPD-SNBL in Japan
    • Functional Service Partnership Solutions
    • Industry Trends
    • Accelerator Drug Development
    • Site and Patient Recruitment Solutions
  • Our Solutions
    • Clinical Development
      • Early Development
      • Government and Public Health
      • Phase II-IV Clinical Trial Management
        • Biostatistics
        • Clinical Data Management
        • Clinical Trial Monitoring
        • Clinical Trial Project Management
        • Global Clinical Supplies
        • Interventional Studies
        • Medical Writing
        • Pharmacokinetic and Pharmacodynamic
        • Pharmacovigilance
      • Real-World Evidence
        • Observational Studies
        • Real-World Data and Scientific Solutions
        • Pregnancy and Lactation Studies
        • PPD Evidera Patient-Centered Research
        • PPD Evidera Implementation Science
      • Proprietary Real-World Data
        • PPD CorEvitas Clinical Registries
        • PPD CorEvitas Precision Medicine
        • PPD Vestrum Health Real-World Data
      • PPD Evidera Health Economics & Market Access
        • PPD Evidera Health Economics
        • PPD Evidera Market Access 
      • PPD Biotech Solutions
      • PPD Functional Service Partnership Solutions
        • Biostatistics and Programming
        • Clinical Data Management
        • Clinical Operations
        • Feasibility
        • Global Clinical Supplies
        • Medical Writing
        • Pharmacovigilance
        • Project Delivery
        • Regulatory Affairs
        • Site Contracts and Payments
        • Site Support
        • Study Startup
        • Quality Assurance
        • Insights Hub: PPD FSP Solutions
      • PPD Translate Solutions
      • Medical Communications
      • Regulatory Affairs Solutions
      • Site and Patient Centric Solutions
        • Accelerated Enrollment Solutions (AES)
        • Enrollment and Site Activation
        • Integrating the Patient Voice
        • Leveraging Technology
      • Technology
        • Data Capabilities
        • Patient First Digital Solutions
        • Information Security
        • Preclarus
        • Support Systems and Services
    • PPD Laboratory Services
      • Bioanalytical Lab
        • Bioanalytical Lab Capabilities
        • Bioanalytical Lab Experience and Expertise
        • Bioanalytical Lab Tech Talks
        • Bioanalytical Lab Resources
      • Biomarker Capabilities
        • Biomarker Expertise and Capabilities
        • Biomarker Capabilities Resources
      • Central Lab
        • Central Lab Capabilities
        • Certifications
        • Preclarus Lab Solutions
        • Central Lab Resources
      • GMP Lab
        • GMP Lab Capabilities
        • GMP Lab Experience and Expertise
        • Athlone Lab
        • GMP Lab Resources
      • Vaccine Sciences Lab
        • Vaccine Sciences Lab Capabilities
        • Vaccine Sciences Lab Resources
      • Lab Services in China
      • PPD Laboratory Services FSP
  • Therapeutic Areas
    • Biosimilar Development
    • Cardiovascular
    • Cell & Gene Therapy
    • Critical Care
    • Dermatology
    • Hepatology
    • Gastroenterology
    • Immunology and Rheumatology
      • Lupus
    • Infectious Diseases
    • Metabolic and Endocrine
      • Diabetes
      • Rare Metabolic Disease
    • Nephrology and Renal Diseases
    • Neuroscience Research
      • Neurodegenerative Disease Research Expertise
      • Psychiatry
      • Neuroinflammatory Diseases
    • Oncology and Hematology
    • Ophthalmology
    • Pediatrics
    • Rare Diseases
      • Neuromuscular Disorder Studies
      • Rare Metabolic Disease
      • Rare Neurological Disorders
    • Respiratory
    • Urology
    • Vaccine Development
    • Women’s Health
  • Participate in a Trial
abstract gray background
Case Study - Conversion to sole-provider FSP model beats schedule, exceeds expectations
Case Study - Conversion to sole-provider FSP model beats schedule, exceeds expectations

Conversion to a Sole-provider FSP Model

Learn how our FSP experts delivered process improvements that outperformed customer goals.

Learn how our FSP experts delivered process improvements that outperformed customer goals

  • Legal Notices
  • Site Map
  • Modern Slavery Transparency Statement
  • Privacy Policy
©2025 Thermo Fisher Scientific Inc. All Rights Reserved.
  • Contact Us
  • LinkedIn
  • Twitter
  • Facebook
  • Instagram
  • YouTube
  • Events